BioSig Technologies Inc. (BSGM)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 1.16 |
Market Cap | 19.99M |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | -1.34 |
PE Ratio (ttm) | -0.87 |
Forward PE | n/a |
Analyst | Strong Buy |
Ask | 1.26 |
Volume | 173,599 |
Avg. Volume (20D) | 351,237 |
Open | 1.19 |
Previous Close | 1.20 |
Day's Range | 1.16 - 1.27 |
52-Week Range | 0.20 - 2.98 |
Beta | undefined |
About BSGM
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses ...
Analyst Forecast
According to 1 analyst ratings, the average rating for BSGM stock is "Strong Buy." The 12-month stock price forecast is $2.75, which is an increase of 137.07% from the latest price.
Why Price Moved
News
2 years ago · proactiveinvestors.com
BioSig Technologies says Kansas City Heart Institute signs purchase agreement for its PURE EP SystemBioSig Technologies Inc has announced that Kansas City Heart Institute at Overland Park Regional Medical Center in Kansas City, USA, has signed a purchase agreement to acquire its PURE EP System. Foll...
2 years ago · proactiveinvestors.com
BioSig Technologies gets repeat 'Outperform' tag, $4 price target from Noble CapitalBioSig Technologies Inc has earned a reiterated ‘Outperform' rating and $4 price target from analysts at Noble Capital days after pricing a public offering that generated proceeds of $2.9 million. Th...
2 years ago · proactiveinvestors.com
BioSig Technologies says it intends to offer shares of its common stock in a "best efforts" underwritten public offeringBioSig Technologies, Inc. (NASDAQ:BSGM) has said it intends to offer shares of its common stock in a "best efforts" underwritten public offering. BioSig said it intends to use the net proceeds from th...
2 years ago · proactiveinvestors.com
BioSig Technologies enters deal for Cleveland Clinic to evaluate its PURE EP signal processing platformBioSig Technologies, Inc. (NASDAQ:BSGM) said it has entered into an evaluation agreement for its PURE EP System with Cleveland Clinic, its first following the induction of a new commercialization team...
2 years ago · proactiveinvestors.com
BioSig targets July 1 to launch national PURE EP commercial campaignBioSig Technologies Inc plans to kick off a national commercial launch campaign for its PURE EP System on July 1, 2022 following multiple initiatives to accelerate its transition from limited market r...
2 years ago · proactiveinvestors.com
BioSig maintains ‘Outperform' rating from Noble Capital as "stronger commercialization efforts” underway for its PURE EP systemBioSig Technologies Inc drew an ‘Outperform' rating from Noble Capital, which noted that "stronger commercialization efforts” are underway for the company's PURE (Precise Uninterrupted Real-time evalu...
2 years ago · proactiveinvestors.com
BioSig Technologies completes its previously announced underwritten public offering for proceeds of $3 millionBioSig Technologies Inc has announced the completion of its previously announced underwritten public offering of 2,611,739 shares of its common stock at a price to the public of $1.15 per share for pr...
2 years ago · proactiveinvestors.com
BioSig Technologies to raise $3M in equity financing with family investment officeBioSig Technologies Inc announced that it has agreed to sell $3 million of its common stock and warrants to a family office, which the company said has deep expertise in small-cap emerging growth inve...
2 years ago · proactiveinvestors.com
BioSig Technologies receives boost for its PURE EP technology with award of patent claimsBioSig Technologies Inc, the medtech group, has announced another boost for its heart monitoring technology, revealing that the US Patent Office had awarded patent claims for its PURE EP noise-filteri...